SEC Company Response from CRESCENT BIOPHARMA, INC. (CBIO) (CIK 0001253689) (CBIO) — May 23, 2019
CRESCENT BIOPHARMA, INC. (CBIO) (CIK 0001253689)
Date: May 23, 2019 · CIK: 0001253689 · Accession: 0001104659-19-031465
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-231577
Letter
VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Registration Statement on Form S-3, File No. 333-231577 Acceleration Request Requested Date: Tuesday, May 28, 2019 Requested Time: 4:00 p.m. Eastern Time
Re: GlycoMimetics, Inc. (the “Registrant”)
Dear Ms. Westbrook:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-231577) (the “Registration Statement”) to become effective on Tuesday, May 28, 2019, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the “Staff”).
Once the Registration Statement has been declared effective, please orally confirm that event with Katie Kazem of Cooley LLP, counsel to the Registrant, at (703) 456-8043, or in her absence, Brian Leaf at (703) 456-8053.
Very truly yours,
GLYCOMIMETICS, INC.
Show Raw Text
CORRESP 1 filename1.htm May 23, 2019 VIA EDGAR Ms. Christine Westbrook Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Re: GlycoMimetics, Inc. (the “Registrant”) Registration Statement on Form S-3, File No. 333-231577 Acceleration Request Requested Date: Tuesday, May 28, 2019 Requested Time: 4:00 p.m. Eastern Time Dear Ms. Westbrook: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-231577) (the “Registration Statement”) to become effective on Tuesday, May 28, 2019, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the “Staff”). Once the Registration Statement has been declared effective, please orally confirm that event with Katie Kazem of Cooley LLP, counsel to the Registrant, at (703) 456-8043, or in her absence, Brian Leaf at (703) 456-8053. Very truly yours, GLYCOMIMETICS, INC. By: /s/ Brian M. Hahn Brian M. Hahn Chief Financial Officer